Clinical Case Reports (Dec 2022)
Toxic epidermal necrosis following Sinopharm COVID‐19 vaccine (BBIBP‐CorV): A case report and literature review
Abstract
Abstract This study reports a patient developing TEN after the first dose of (BBIBP‐CorV). He developed numerous purpuric and dusky patches with flaccid bullae and areas of epidermal detachment covered more than 30% of the body area within 6 days. After treatment with dexamethasone and cyclosporin, he recovered within 14 days.
Keywords